Showing results (351-360 of 370) with videos related to

Sort By:
Pageof 37
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
Scientific Reports|February 8, 2019
Combined quantification of intracellular (phospho-)proteins and transcriptomics from fixed single cellsJan P Gerlach, Jessie A G van Buggenum, Sabine E J Tanis, et al.
AIDS (London, England)|April 5, 2017
Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patientsWard P H van Bilsen, Charlotte H S B van den Berg, Bart J A Rijnders, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]M Jambroes, G J Weverling, P Reiss, et al.
AIDS (London, England)|August 26, 1998
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyR M Hoetelmans, M H Reijers, G J Weverling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacyD M Burger, P W Hugen, R E Aarnoutse, et al.
The Journal of Biological Chemistry|December 21, 2018
The catalytic mechanism of electron-bifurcating electron transfer flavoproteins (ETFs) involves an intermediary complex with NADGerrit J Schut, Nishya Mohamed-Raseek, Monika Tokmina-Lukaszewska, et al.
The Journal of Infectious Diseases|June 1, 1996
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative GroupR T Schooley, C Ramirez-Ronda, J M Lange, et al.
Nature Chemical Biology|April 11, 2017
Mechanistic insights into energy conservation by flavin-based electron bifurcationCarolyn E Lubner, David P Jennings, David W Mulder, et al.
Gastroenterology|August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virusTheodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Pageof 37